Advanced search
Publication Cover
Acta Cardiologica Volume 74, 2019 - Issue 4
Submit an article Journal homepage
322
Views
16
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

Frank CoolsAZ Klina, Brasschaat, Antwerp, Belgium; Correspondence[email protected]
View further author information
,
Bart WollaertZNA Antwerpen, Belgium; View further author information
,
Geert VervoortAZ Sint-Maarten, Mechelen, Belgium; View further author information
,
Stefan VerstraeteAZ Zeno Knokke, Belgium; View further author information
,
Joeri VoetAZ Nikolaas Sint Niklaas, Belgium; View further author information
,
Kurt HermansAZ Sint Lucas Gent, Belgium; View further author information
,
Alex HeyseAZ Glorieux Ronse, Belgium; ORCID Iconhttp://orcid.org/0000-0002-6364-6074View further author information
ORCID Icon,
Axel De WolfHeilig Hart Ziekenhuis Tienen, Belgium; View further author information
,
Geert HollandersPrivate Practice De Pinte, Belgium; View further author information
,
Tim BoussyAZ Groeninge, Kortrijk, Belgium; View further author information
,
Wim AnnéAZ Delta, Roeselare, Belgium; View further author information
,
Jan VercammenYperman Ziekenhuis Ieper, Belgium; View further author information
,
Dirk FaesMariaziekenhuis Noord Limburg, Belgium; View further author information
,
Michel BeutelsHuisartsen Het Laar, Merksem, Belgium; View further author information
,
Georges MairesseCliniques Sud Luxembourg Arlon, Belgium; View further author information
,
Philippe PurnodeCliniques St. Jean Bruxelles, Belgium; View further author information
,
Ivan BlankoffCHU de Charleroi, Belgium; View further author information
,
Peter VandergotenPrivate Practice, Overijse, Belgium; View further author information
,
Luc CapiauWetteren, Belgium; View further author information
,
Jagan AlluThrombosis Research Institute, London, UK; View further author information
,
Jean-Pierre BassandThrombosis Research Institute, London, UK; ;University of Besançon, FranceView further author information
,
Gloria KayaniThrombosis Research Institute, London, UK; View further author information
& for the GARFIELD-AF Investigators show all
Pages 309-318 | Received 04 May 2018, Accepted 22 Jun 2018, Published online: 27 Oct 2018

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Elvire Nakhoul, Bert Vaes, Pavlos Mamouris & Jean-Marie Degryse. (2023) Trends in oral anticoagulant prescription in patients with nonvalvular atrial fibrillation in Flanders and the impact of switching patients from vitamin K antagonists to DOACS in terms of the burden caused by complications of the disease: a registry-based study. Acta Clinica Belgica 78:4, pages 261-269.
Read now
Jean-Pierre Bassand, Patricia N Apenteng, Dan Atar, A John Camm, Frank Cools, Ramon Corbalan, David A Fitzmaurice, Keith AA Fox, Shinya Goto, Sylvia Haas, Werner Hacke, Carlos Jerjes-Sanchez, Yukihiro Koretsune, Jean-Yves Le Heuzey, Jitendra PS Sawhney, Seil Oh, Janina Stępińska, Vincent ten Cate, Freek WA Verheugt, Gloria Kayani, Karen S Pieper, Ajay K Kakkar & for the GARFIELD-AF investigators. (2021) GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke. Future Cardiology 17:1, pages 19-38.
Read now
Marc J. Claeys, Michel De Pauw, Peter Geelen, Patrizio Lancellotti & Luc Pierard. (2020) Review article: the best of 2018. Acta Cardiologica 75:5, pages 383-387.
Read now
Kevser Gülcihan Balci, Mustafa Mücahit Balcı, Elif Hande Çetin, Özlem Özcan Çelebi & Orhan Maden. (2020) Lower rates of vitamin-K-antagonists usage are also related to physicians’ and patients’ comfort with novel oral anticoagulants. Acta Cardiologica 75:1, pages 95-95.
Read now

Articles from other publishers (12)

U. D. Filonova, P. K. Karnakova, K. K. Karnakova, M. O. Popova, A. A. Popova, O. A. Archakova, T. N. Komarov & I. E. Shohin. (2024) Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma. Drug development & registration 13:1, pages 224-240.
Crossref
Lieselotte Knaepen, Michiel Delesie, Johan Vijgen, Paul Dendale, Joris Ector, Lien Desteghe & Hein Heidbuchel. (2023) Adherence to oral anticoagulation measured by electronic monitoring in a Belgian atrial fibrillation population. Clinical Research in Cardiology 112:12, pages 1812-1823.
Crossref
Ojasav Sehrawat, Anthony H. Kashou, Holly K. Van Houten, Ken Cohen, Henry Joe Henk, Bernard J. Gersh, Neena S. Abraham, Jonathan Graff-Radford, Paul A. Friedman, Konstantinos C. Siontis, Peter A. Noseworthy & Xiaoxi Yao. (2023) Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era. IJC Heart & Vasculature 46, pages 101212.
Crossref
Maxim Grymonprez, Tine L. De Backer, Andreas Capiau, Delphine Vauterin, Els Mehuys, Koen Boussery, Stephane Steurbaut & Lies Lahousse. (2022) Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study. British Journal of Clinical Pharmacology 89:4, pages 1360-1373.
Crossref
E. V. Tavlueva, O. N. Savkova, E. V. Zernova, S. A. Berns & O. M. Drapkina. (2023) Prevalence of oral anticoagulant therapy in clinical practice in patients hospitalized with acute ischemic stroke. Russian Journal of Cardiology 27:12, pages 5149.
Crossref
Maxim Grymonprez, Andreas Capiau, Stephane Steurbaut, Els Mehuys, Koen Boussery, Tine L. De Backer & Lies Lahousse. (2022) Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study. Frontiers in Cardiovascular Medicine 9.
Crossref
Souad Moudallel, Pieter Cornu, Alain Dupont & Stephane Steurbaut. (2021) Determinants for under‐ and overdosing of direct oral anticoagulants and physicians' implementation of clinical pharmacists' recommendations. British Journal of Clinical Pharmacology 88:2, pages 753-763.
Crossref
Thibaud Cavaillez, Laurent Weinmann, Christine Mouton, Céline Delassasseigne, Musa Sesay, Matthieu Biais, Chloé James & Stéphanie Roullet. (2021) A retrospective study of indications and consequences of monitoring direct oral anticoagulant plasma concentrations on patient care in a university hospital: The Retro-AOD study. Thrombosis Research 206, pages 76-83.
Crossref
Eyob Alemayehu Gebreyohannes, Sandra Salter, Leanne Chalmers, Luke Bereznicki & Kenneth Lee. (2020) Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence. American Journal of Cardiovascular Drugs 21:4, pages 419-433.
Crossref
Jaap Seelig, Martin E.W. Hemels, Olivier Xhaët, Maarten C.M. Bongaerts, Axel de Wolf, Björn E. Groenemeijer, Alex Heyse, Pieter Hoogslag, Joeri Voet, Jean‐Paul R. Herrman, Geert Vervoort, Walter Hermans, Bart Wollaert, Lucas V.A. Boersma, Kurt Hermans, Andreas Lucassen, Stefan Verstraete, Henk J. Adriaansen, Georges H. Mairesse, Willem F. Terpstra, Dirk Faes, Mathijs Pieterse, Saverio Virdone, Freek W.A. Verheugt, Frank Cools & Hugo ten Cate. (2020) Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry. Journal of Thrombosis and Haemostasis 18:12, pages 3280-3288.
Crossref
Juan Manuel  Solís Soto, Mario Alberto  Carrillo Pérez,  Sergio Antonio  Ramírez Ríos & Carlos Alberto Solís Olivares. (2020) Prevalencia y perfil clínico-terapéutico de la fibrilación auricular en consultorios de cardiología privados del noreste de México. Cardiovascular and Metabolic Science 31:2, pages 40-48.
Crossref
Kevser Gülcihan Balci, Özlem Özcan Çelebi, Mustafa Mücahit Balcı, Sinan Aydoğdu & Mehmet İleri. (2019) Atrial fibrillation and health‐related quality of life. Pacing and Clinical Electrophysiology 43:1, pages 156-156.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.